ARCA biopharma, Inc.
(NASDAQ : ABIO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-1.25%194.261.3%$534.90m
GILDGilead Sciences, Inc.
-0.39%65.910.9%$358.61m
ALXNAlexion Pharmaceuticals, Inc.
-4.94%102.502.0%$309.45m
ILMNIllumina, Inc.
1.18%301.783.5%$306.80m
BIIBBiogen Inc.
-1.42%235.311.3%$295.44m
CELGCelgene Corporation
0.12%98.721.3%$288.72m
SRPTSarepta Therapeutics, Inc.
-2.38%82.8614.6%$174.60m
AAgilent Technologies, Inc.
0.58%76.841.6%$174.34m
VRTXVertex Pharmaceuticals Incorporated
-0.85%174.501.9%$173.05m
REGNRegeneron Pharmaceuticals, Inc.
-2.09%282.092.6%$168.99m
EXASExact Sciences Corporation
-1.70%105.0524.1%$132.89m
ACADACADIA Pharmaceuticals Inc.
-3.78%40.9913.9%$110.63m
INCYIncyte Corporation
-1.39%78.002.5%$84.52m
BMRNBioMarin Pharmaceutical Inc.
0.65%75.494.3%$71.69m
ALDRAlder Biopharmaceuticals, Inc.
0.32%18.7610.2%$64.14m

Company Profile

ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company engages in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, GencaroTM is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.